Booster Ebola vaccine enters first trials at Oxford University | University of Oxford
The COV-BOOST Trial: Safety and Immunogenicity of Boosters - REBEL EM - Emergency Medicine Blog
Washington University participates in clinical trial of Moderna omicron booster – Washington University School of Medicine in St. Louis
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Infectious Diseases
Safety and immunogenicity of seven COVID-19 vaccines as a third dose ( booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV- BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial -
Trial confirms safety of mix-and-match COVID-19 vaccine booster | KPWHRI
Moderna on X: "In a Phase 2/3 trial in over 500 adults, mRNA-1273.222, induced significantly higher neutralizing antibody titers against BA.4/BA.5 compared to a booster dose of mRNA-1273. Read more: https://t.co/CPnxL03nZW https://t.co/ODihw6qtsQ" /
Updated results from COVID-19 vaccine booster trial | KPWHRI
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial | Nature Medicine
New global vaccine trial launched to evaluate fractional COVID-19 booster shots - Murdoch Children's Research Institute
Baylor launches clinical trial for COVID-19 vaccine booster | BCM
third covid vaccine booster trial | University of Southampton
Major COVID-19 booster trial looks at how best to improve immunity against coronavirus in vulnerable people | NIHR
Vaccine trial to investigate a booster for teenagers to protect against COVID-19 | Health Care Research Wales
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial - The Lancet
UMass Medical School to participate in trial of Pfizer COVID-19 booster vaccine
Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial | Nature Medicine
Studying COVID-19 booster vaccines | Fall 2021 | UC Davis Health Magazine
Booster trial aims to improve immunity in vulnerable people – UKRI
MultiCare launches COVID-19 vaccine booster trial - Newsroom
Skin Hydrating Booster Trial - Bio Aesthetic
Volunteers sought for vaccine trial of COVID-19 booster | Newsroom
Cambridge begins world-first COVID-19 vaccine booster study - NIHR - Cambridge Clinical Research Facility
News - Major Covid-19 booster trial looks at how best to improve immunity against coronavirus in vulnerable people - University of Nottingham
UK launches extensive trial of third booster shots of Covid vaccines
Moderna starts trial for Omicron-specific booster shot | Reuters
